Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

http://www.wikidata.org/entity/Q37246570

about

Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma Biomarkers for the early diagnosis of hepatocellular carcinoma Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.New paradigms in translational science research in cancer biomarkers Semi-quantitative measurement of a specific glycoform using a DNA-tagged antibody and lectin affinity chromatography for glyco-biomarker development Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.Screening and surveillance for hepatocellular carcinoma: perspective of a new era?Imaging and 'omic' methods for the molecular diagnosis of cancer.Current management of hepatocellular carcinoma.Fucosylation is a promising target for cancer diagnosis and therapy miR-365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl-2.Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinoma Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.Updates in the management of hepatocellular carcinoma Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively.Serum levels of soluble CD25 as a marker for hepatocellular carcinoma Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.Role of surveillance in prevention of hepatocellular carcinoma.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.Clinical utility of protein induced by vitamin K absence in patients with chronic hepatitis B virus infection Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma.Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis.Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study

P2860

Q24635267-3CFAFBB0-B998-4766-BAD1-CD02299AADAA Q26740317-143E2C56-4AA3-457F-B542-26707060F4AF Q26743361-C5D50203-5FDB-469A-BEBB-E3DCA93D51A1 Q26772324-04DE9CFD-4737-4E10-8A17-D1539A4DDB39 Q26784418-36476547-E452-4F44-B511-BD5CF445F5C1 Q26863560-63F40A7B-A2B1-4E22-BB61-D124529F9814 Q27003291-239D3334-8DA5-4A12-89F0-2100225D91DC Q27005375-2DCB53E1-40A4-4631-AFC6-0755CE23B315 Q27016138-4563FD89-5353-4D4D-8528-9DA7AE5F58E9 Q27027893-D899ECB9-4E47-4E24-8969-23BE49603BAE Q27311617-3FCDBE6D-B5ED-46EA-B0ED-98FC7C3B9EC7 Q28080175-827C16E1-CD16-4AA0-8A9F-B7DAAB8F60AF Q28082223-3CC92056-D219-46B7-882F-093C9D5846FE Q30151390-EE4A7328-82D0-4D0D-A416-A5F3EDE81249 Q30244651-3EB78B75-A34D-4FCF-A802-8F2998782FE2 Q33577268-0E9B2514-B62B-4D97-B5D1-2BCAFFBDFE0F Q33582165-17B27E7B-E29A-4BB2-8126-8854A7E19FAA Q33649601-8CAA02FF-9B51-4248-9EFA-F9769A47D2D6 Q33723964-BD90310A-9E48-45B1-844D-65CCABFB9F0B Q33752079-221FE5B9-F8FD-4C29-A26C-B71314B07141 Q33753952-1D09741E-500B-4642-97BB-82E30121F197 Q33761846-8E993A62-0FE7-43A3-93CB-73A2B1D11704 Q34409128-B64D30DB-8106-4B07-BE9B-104FC4E0A00B Q34471532-04F8FCBA-A41C-48A2-AE12-1ACEEE0C3EEE Q34530671-0598DD25-1357-443C-9746-EBBD328FAD16 Q34571160-F3D60074-71A8-4E5A-8C46-A7942272F82D Q34631965-E3AECBB5-938D-4208-A2BF-DB5DEB2AF94B Q34645945-1E2405EB-ACBD-4996-BB47-2FA64A5E312E Q34759365-7D89D900-DA8A-4DE8-87F1-5C4CD1C16955 Q34826014-6D75E102-4666-4533-A9A9-89DD9ABF9251 Q34826535-0921DD09-0C16-4F68-AFCF-41619DD14465 Q34851700-3741F847-65D6-4D35-A224-4E7618103944 Q35062428-8E016739-9A90-4659-A58B-22911C2AB5C0 Q35125611-89C021CB-7460-4806-A7FB-85AD7DD48DAC Q35270302-8B84E560-EA4B-4925-B922-C024777849B8 Q35581398-A4FDA447-D85C-4B88-9520-C1C7465EAE06 Q35650689-93942061-4FA7-4243-8493-CE553940697B Q35669106-188C4B18-9A07-442A-80C5-F19B375FCA98 Q35677687-0F76042A-6A5E-4D45-8ED4-E27450CFB5CD Q35764990-EC70347C-E626-462A-8F5E-2707C3B2A3AB

P2860

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

http://www.wikidata.org/entity/Q37246570

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Alpha-fetoprotein, des-gamma c ...... early hepatocellular carcinoma

@en

Alpha-fetoprotein, des-gamma c ...... arly hepatocellular carcinoma.

@nl

type

label

Alpha-fetoprotein, des-gamma c ...... early hepatocellular carcinoma

@en

Alpha-fetoprotein, des-gamma c ...... arly hepatocellular carcinoma.

@nl

prefLabel

Alpha-fetoprotein, des-gamma c ...... early hepatocellular carcinoma

@en

Alpha-fetoprotein, des-gamma c ...... arly hepatocellular carcinoma.

@nl

P1433

Q37246570-84FBD5CE-F616-4E0E-894C-21609B34DDC1

P1476

Q37246570-F83E66CD-3038-47A3-ABE5-0360E37B216C

P2093

Q37246570-0BE78326-3DA7-46BE-B4DA-57D99A804371

Q37246570-0D949AA6-BC47-4280-8390-66CE8C37D7A7

Q37246570-0F956B5B-4D01-4089-8082-C7C4E59F0BE4

Q37246570-4D3DAB36-5718-4FCF-8AD7-D403BFA2841F

Q37246570-8F569A19-AB39-49B8-BC31-E74842AD027A

Q37246570-A93B6240-6F0B-43EF-B4A5-FAB5D796F1D7

Q37246570-C7DA49EE-F308-4F6B-8F96-A4F3EDC2FE8A

Q37246570-C7DC079A-05A6-466D-BD52-4EAC72FDDD11

Q37246570-D01FACC2-A894-411F-961C-CAFDE75CA6EC

Q37246570-D9A320FF-1733-4A66-872D-A1AEB987A7AC

P2860

Q37246570-23651AA1-85AB-445C-923E-701F5E3411FA

Q37246570-25D6BDE6-4395-402D-8E37-97A06621F0C1

Q37246570-2B890881-B218-491D-9EDB-44DF8933CE66

Q37246570-4305C498-CABA-44AD-8759-49324D381981

Q37246570-7F680FB8-8F55-4017-A5C1-2FE8EFA4D7B9

Q37246570-908B3D5E-5773-492E-BDD0-39708C24AA50

Q37246570-97A588A1-0040-43DB-BD3C-638E1826D86E

Q37246570-A469DF3D-D498-428D-9824-962585CBC25B

Q37246570-B0FAB3B4-4959-4CF1-983A-27D0DF49A9B7

Q37246570-BCE3C02D-8017-42BE-A04A-812DC79D3E55

P304

Q37246570-6CC3846B-69D8-48E3-88F5-FBA13B1E3EE4

P31

Q37246570-B7F7B1B6-2AA7-4721-8060-268CBBD3B8FE

P356

Q37246570-B6BD7C67-80AC-48FF-B5AA-D57ED6FFACBE

P407

Q37246570-67A75373-9C7B-45F7-9A50-234ECD08733E

P433

Q37246570-0CFB79C6-C969-46F3-BFB6-AAD22494AE1A

P478

Q37246570-841C23FA-E81A-4B18-A8F2-DFDF41EB8909

P50

Q37246570-19379053-9DA9-459F-93AF-62C49225CEBB

Q37246570-E0920EF7-EDE9-4EAB-8BEB-9BBC48BD6101

Q37246570-E6A36CA0-C5C3-4DF3-A54D-CAFB7322C73A

P577

Q37246570-CA5E7461-A61C-460A-B583-6DB22E3D5B6A

P698

Q37246570-97D328F3-A714-42AE-9B6D-56809871E401

P932

Q37246570-46FB0F79-F32A-49DB-BB5E-6858F76D5A67

P356

J.GASTRO.2009.04.005

P1433

Gastroenterology

P1476

Alpha-fetoprotein, des-gamma c ...... early hepatocellular carcinoma

@en

P2093

Alex S Befeler

http://www.w3.org/2001/XMLSchema#string

Anna S Lok

http://www.w3.org/2001/XMLSchema#string

David Chia

http://www.w3.org/2001/XMLSchema#string

Denise Harnois

http://www.w3.org/2001/XMLSchema#string

Jackie Dalhgren

http://www.w3.org/2001/XMLSchema#string

Jorge A Marrero

http://www.w3.org/2001/XMLSchema#string

K Rajender Reddy

http://www.w3.org/2001/XMLSchema#string

Mindie H Nguyen

http://www.w3.org/2001/XMLSchema#string

Myron Schwartz

http://www.w3.org/2001/XMLSchema#string

Paul D Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

The global health burden of infection-associated cancers in the year 2002

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Phases of biomarker development for early detection of cancer.

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.

Hepatocellular carcinoma: recent trends in the United States.

P304

110-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2009.04.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Josep M. Llovet

Lewis R. Roberts

Daniel P. Normolle

P577

2009-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19362088

http://www.w3.org/2001/XMLSchema#string

P932

2704256

http://www.w3.org/2001/XMLSchema#string